Paolo Peccoz-Beck

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

Reply to the letter by Dr Karlsson 'Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?'

Reply to the letter by Dr Karlsson 'Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?'

Journal: European thyroid journal

Published: August 20, 2025

Retraction Note: High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells.

Retraction Note: High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells.

Journal: Oncogene

Published: July 28, 2025

Safety and Effectiveness of a Biosimilar Recombinant Growth Hormone in Adults with Growth Hormone Deficiency: Analysis of Final Data from PATRO Adults, an International Post-Marketing Surveillance Study.

Safety and Effectiveness of a Biosimilar Recombinant Growth Hormone in Adults with Growth Hormone Deficiency: Analysis of Final Data from PATRO Adults, an International Post-Marketing Surveillance Study.

Journal: Drug design, development and therapy

Published: July 25, 2024

2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action.

2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action.

Journal: European thyroid journal

Published: April 23, 2024

Discoveries Around the Hypothalamic-Pituitary-Thyroid Axis.

Discoveries Around the Hypothalamic-Pituitary-Thyroid Axis.

Journal: Thyroid : official journal of the American Thyroid Association

Published: January 30, 2023

Expression of Concern: Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells.

Expression of Concern: Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells.

Journal: Journal of cell science

Published: November 28, 2022

Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults).

Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults).

Journal: Pituitary

Published: February 26, 2021

Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs.

Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs.

Journal: Expert opinion on drug safety

Published: October 22, 2020

Skeletal health in patients with differentiated thyroid carcinoma.

Skeletal health in patients with differentiated thyroid carcinoma.

Journal: Journal of endocrinological investigation

Published: May 19, 2020

The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience.

The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience.

Journal: Frontiers in endocrinology

Published: April 11, 2020

Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from the PATRO Adults study.

Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from the PATRO Adults study.

Journal: Therapeutic advances in endocrinology and metabolism

Published: March 13, 2020

No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study.

No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study.

Journal: BMC endocrine disorders

Published: May 31, 2019

Showing 1-12 of 101

Last Updated: 09/26/2026